Thermal Medicine
Online ISSN : 1882-3750
Print ISSN : 1882-2576
ISSN-L : 1882-2576
Volume 38, Issue 1
Displaying 1-5 of 5 articles from this issue
    2022 Volume 38 Issue 1 Pages 1-18
    Published: March 15, 2022
    Released on J-STAGE: April 18, 2022

    Plasma medicine is a rapidly expanding new field of interdisciplinary research that combines physics, chemistry, biology, and medicine. Non-thermal atmospheric pressure plasma (NTAPP) has recently been applied to living cells and tissues, and has emerged as a novel technology for medical applications, such as sterilization, wound healing, blood coagulation, and cancer treatment. NTAPP was found to affect cells indirectly through the treatment of cells with previously prepared medium irradiated by NTAPP, termed plasma-activated medium (PAM). We found that PAM triggered a spiral apoptotic cascade in the mitochondrial-nuclear-membrane network in A549 cancer cells. However, difficulties are associated with applying PAM to the clinical phase because culture media cannot be used for medical treatments. The antitumor activity of NTAPP-activated acetate Ringer’s solution (PAA) was significantly stronger than that of PAM. PAA maintained its ability for at least 1 week stored at any temperature tested, whereas PAM was stable only at -80 ℃. At the end, we herein demonstrated the advantages of the combined application of PAA and hyperthermia, a heat treatment at 42 ℃, for A549 cancer cell death with increases in intracellular calcium ([Ca2+]i). The activation of transient receptor potential melastatin 2 (TRPM2) may enhance cell death because the addition of TRPM2 inhibitors and knockdown of TRPM2 significantly abrogated the above phenomena. TRPM2 is a temperature-sensitive, Ca2+-permeable, non-selective cation channel, and hydrogen peroxide (H2O2) and ADP-ribose are its main agonists. PAA functioned as a donor of reactive oxygen species, mainly H2O2, and a treatment of A549 cells with PAA under hyperthermia enhanced both mitochondrial and nuclear damage with DNA breaks. Although further studies are needed, the results of our studies provide evidence for the antitumor effects of the synergism between NTP-irradiated liquid and hyperthermia as well as its potential for clinical applications.

    Download PDF (1394K)
Original Paper
    2022 Volume 38 Issue 1 Pages 19-26
    Published: March 15, 2022
    Released on J-STAGE: April 18, 2022

    Magnetite cationic lipid composite particles (MCL particles, formerly named magnetite cationic liposomes) injected in tumor tissue has been shown to expand tumor necrosis area stepwisely by multiple alternating magnetic field (AMF) irradiations which triggered heat generation of MCL particles. This study investigated mode of tumor necrosis induction and process of MCL particles dispersion in vivo in order to verify therapeutic protocol.

    Tumor necrosis area induced by the 1st AMF irradiation showed amoeba-like shape with clear outline owing to area where MCL particles distributed. During 24 hours after the irradiation, almost all MCL particles disappeared from the necrosis area, and dispersed to neighbor naïve tumor zone and accumulated in interstitial spaces of alive tumor cells. Structural change of dispersed MCL particles was not observed in situ by electron microscopy. The data verified necessity of time intervals between AMF irradiations for particle dispersion and reusage of MCL particles in following multiple AMF irradiations. Dispersion and infiltration of MCL particles toward surrounding normal tissue were not observed and its mechanism was shortly discussed together with driving forces of the particle dispersion in vivo.

    Download PDF (1652K)